AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $6.37M invested in Akari Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

more funds holding

Funds holding: →

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.7M
2
+$2.58M
3
+$24.8K
4
OFW
Omnia Family Wealth
Florida
+$15.3K
5
Millennium Management
Millennium Management
New York
+$14.9K

Top Sellers

1
-$33K
2
-$15K
3
-$12K
4
Renaissance Technologies
Renaissance Technologies
New York
-$3.68K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.7M
2
$2.58M
3
$493K
4
$285K
5
$82K
6
$77K
7
$63K
8
$25K
9
$24K
10
$19K
11
$13K
12
$2K
13
$1K
14
–
15
–
16
–